相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。In vitro susceptibility patterns for rapidly growing nontuberculous mycobacteria in the United States
Joshua -J. Hunkins et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2023)
Potency of Omadacycline against Mycobacteroides abscessus Clinical Isolates In Vitro and in a Mouse Model of Pulmonary Infection
Danielle A. Nicklas et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2022)
Treatment of Mycobacterium abscessus Pulmonary Disease
David E. Griffith et al.
CHEST (2022)
Challenges and a potential solution to perform drug susceptibility testing of omadacycline against nontuberculous mycobacteria
Prem Shankar et al.
TUBERCULOSIS (2022)
Omadacycline in first-line combination therapy for pulmonary Mycobacterium abscessus infection: a case series
Marylene Duah et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2022)
In Vitro Susceptibility Testing of Omadacycline against Nontuberculous Mycobacteria
Barbara A. Brown-Elliott et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)
Preliminary, Real-world, Multicenter Experience With Omadacycline for Mycobacterium abscessus Infections
Taylor Morrisette et al.
OPEN FORUM INFECTIOUS DISEASES (2021)
Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline: Executive Summary
Charles L. Daley et al.
CLINICAL INFECTIOUS DISEASES (2020)
Omadacycline for the Treatment of Mycobacterium abscessus Disease: A Case Series
Jeffrey C. Pearson et al.
OPEN FORUM INFECTIOUS DISEASES (2020)
In Vitro Activities of Omadacycline against Rapidly Growing Mycobacteria
Carolyn Shoen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Omadacycline for Acute Bacterial Skin and Skin-Structure Infections
William O'Riordan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Omadacycline for Community-Acquired Bacterial Pneumonia
Roman Stets et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
In Vitro Activity of New Tetracycline Analogs Omadacycline and Eravacycline against Drug-Resistant Clinical Isolates of Mycobacterium abscessus
Amit Kaushik et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
An Integrated Safety Summary of Omadacycline, a Novel Aminomethylcycline Antibiotic
Steven Opal et al.
CLINICAL INFECTIOUS DISEASES (2019)
Omadacycline as a promising new agent for the treatment of infections with Mycobacterium abscessus
Hannelore I. Bax et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)
The REDCap consortium: Building an international community of software platform partners
Paul A. Harris et al.
JOURNAL OF BIOMEDICAL INFORMATICS (2019)
Once-daily oral omadacycline versus twice-daily oral linezolid for acute bacterial skin and skin structure infections (OASIS-2): a phase 3, double-blind, multicentre, randomised, controlled, non-inferiority trial
William O'Riordan et al.
LANCET INFECTIOUS DISEASES (2019)
Tigecycline Is Highly Efficacious against Mycobacterium abscessus Pulmonary Disease
Beatriz E. Ferro et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Advances in the management of pulmonary disease due to Mycobacterium abscessus complex
W-J. Koh et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2014)
Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support
Paul A. Harris et al.
JOURNAL OF BIOMEDICAL INFORMATICS (2009)
Cohort Study of Molecular Identification and Typing of Mycobacterium abscessus, Mycobacterium massiliense, and Mycobacterium bolletii
Adrian M. Zelazny et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2009)